{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["alkaloid", "antinociceptive", "narcotic", "natural product", "opiate", "semi-synthesis"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "37376226", "DateRevised": {"Year": "2023", "Month": "07", "Day": "01"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "06", "Day": "20"}], "Language": ["eng"], "ELocationID": ["1779", "10.3390/pharmaceutics15061779"], "Journal": {"ISSN": "1999-4923", "JournalIssue": {"Volume": "15", "Issue": "6", "PubDate": {"Year": "2023", "Month": "Jun", "Day": "20"}}, "Title": "Pharmaceutics", "ISOAbbreviation": "Pharmaceutics"}, "ArticleTitle": "Synthesis and Modification of Morphine and Codeine, Leading to Diverse Libraries with Improved Pain Relief Properties.", "Abstract": {"AbstractText": ["Morphine and codeine, two of the most common opioids, are widely used in the clinic for different types of pain. Morphine is one of the most potent agonists for the <i>\u03bc</i>-opioid receptor, leading to the strongest analgesic effect. However, due to their association with serious side effects such as respiratory depression, constriction, euphoria, and addiction, it is necessary for derivatives of morphine and codeine to be developed to overcome such drawbacks. The development of analgesics based on the opiate structure that can be safe, orally active, and non-addictive is one of the important fields in medicinal chemistry. Over the years, morphine and codeine have undergone many structural changes. The biological investigation of semi-synthetic derivatives of both morphine and codeine, especially morphine, shows that studies on these structures are still significant for the development of potent opioid antagonists and agonists. In this review, we summarize several decade-long attempts to synthesize new analogues of morphine and codeine. Our summary placed a focus on synthetic derivatives derived from ring A (positions 1, 2, and 3), ring C (position 6), and <i>N</i>-17 moiety."]}, "AuthorList": [{"Identifier": ["0009-0008-1834-4692"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Evin, Tehran 1983963113, Iran."}], "LastName": "Zarin", "ForeName": "Mona Kamelan Zargar", "Initials": "MKZ"}, {"Identifier": ["0000-0002-9597-0629"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Sustainable Chemistry for Metals and Molecules, Department of Chemistry, KU Leuven, Celestijnenlaan 200F, B-3001 Leuven, Belgium."}], "LastName": "Dehaen", "ForeName": "Wim", "Initials": "W"}, {"Identifier": ["0000-0001-5774-3372"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Evin, Tehran 1983963113, Iran."}], "LastName": "Salehi", "ForeName": "Peyman", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, Evin, Tehran 1983963113, Iran."}], "LastName": "Asl", "ForeName": "Amir Ata Bahmani", "Initials": "AAB"}], "GrantList": [{"GrantID": "C14/19/078", "Agency": "KU Leuven", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceutics", "NlmUniqueID": "101534003", "ISSNLinking": "1999-4923"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Patridge E., Gareiss P., Kinch M.S., Hoyer D. An analysis of FDA-approved drugs: Natural products and their derivatives. Drug Discov. Today. 2016;21:204\u2013207. doi: 10.1016/j.drudis.2015.01.009.", "ArticleIdList": ["10.1016/j.drudis.2015.01.009", "25617672"]}, {"Citation": "McCurdy C.R. Analogue-Based Drug Discovery. John Wiley & Sons; Hoboken, NJ, USA: 2006. Development of Opioid Receptor Ligands; pp. 259\u2013276.", "ArticleIdList": ["10.1002/3527608001.ch14"]}, {"Citation": "Robiquet M. Neue Beobachtungen \u00fcber die vorz\u00fcglichsten Produkte aus dem Opium. Eur. J. Org. Chem. 1833;5:82\u2013111. doi: 10.1002/jlac.18330050109.", "ArticleIdList": ["10.1002/jlac.18330050109"]}, {"Citation": "EFSA Panel on Contaminants in the Food Chain (CONTAM) Knutsen H.K., Alexander J., Barreg\u00e5rd L., Bignami M., Br\u00fcschweiler B., Ceccatelli S., Cottrill B., Dinovi M., Edler L., et al. Update of the Scientific Opinion on opium alkaloids in poppy seeds. EFSA J. 2018;16:e05243. doi: 10.2903/j.efsa.2018.5243.", "ArticleIdList": ["10.2903/j.efsa.2018.5243", "PMC7009406", "32625895"]}, {"Citation": "Spetea M., Schmidhammer H. Opioids and Their Receptors: Present and Emerging Concepts in Opioid Drug Discovery. Molecules. 2020;25:5658. doi: 10.3390/molecules25235658.", "ArticleIdList": ["10.3390/molecules25235658", "PMC7730540", "33271753"]}, {"Citation": "Law P.-Y. The Opiate Receptors. Humana Press; Totowa, NJ, USA: 2011. Opioid Receptor Signal Transduction Mechanisms; pp. 195\u2013238.", "ArticleIdList": ["10.1007/978-1-60761-993-2_9"]}, {"Citation": "Patrick G. An Introduction to Medicinal Chemistry. Oxford University Press; Oxford, UK: 2023. p. 658."}, {"Citation": "Sverrisd\u00f3ttir E., Lund T.M., Olesen A.E., Drewes A.M., Christrup L.L., Kreilgaard M. A review of morphine and morphine-6-glucuronide\u2019s pharmacokinetic\u2013pharmacodynamic relationships in experimental and clinical pain. Eur. J. Pharm. Sci. 2015;74:45\u201362. doi: 10.1016/j.ejps.2015.03.020.", "ArticleIdList": ["10.1016/j.ejps.2015.03.020", "25861720"]}, {"Citation": "Andersson M., Bj\u00f6rkhem-Bergman L., Ekstr\u00f6m L., Bergqvist L., Lagercrantz H., Rane A., Beck O. Detection of morphine-3-sulfate and morphine-6-sulfate in human urine and plasma, and formation in liver cytosol. Pharmacol. Res. Perspect. 2014;2:e00071. doi: 10.1002/prp2.71.", "ArticleIdList": ["10.1002/prp2.71", "PMC4186450", "25505615"]}, {"Citation": "Andersson M., Janosik T., Shirani H., Sl\u00e4tt J., Fischer A., Beck O. Synthesis and bioanalytical evaluation of morphine-3-O-sulfate and morphine-6-O-sulfate in human urine and plasma using LC-MS/MS. J. Sep. Sci. 2012;35:367\u2013375. doi: 10.1002/jssc.201100739.", "ArticleIdList": ["10.1002/jssc.201100739", "22258807"]}, {"Citation": "Dinis-Oliveira R.J. Metabolism and metabolomics of opiates: A long way of forensic implications to unravel. J. Forensic Leg. Med. 2018;61:128\u2013140. doi: 10.1016/j.jflm.2018.12.005.", "ArticleIdList": ["10.1016/j.jflm.2018.12.005", "30621882"]}, {"Citation": "Smith H.S. Opioid Metabolism. Mayo Clin. Proc. 2009;84:613\u2013624. doi: 10.1016/S0025-6196(11)60750-7.", "ArticleIdList": ["10.1016/S0025-6196(11)60750-7", "PMC2704133", "19567715"]}, {"Citation": "Bartlett S.E., Smith M.T. The apparent affinity of morphine-3-glucuronide at mu1-opioid receptors results from morphine contamination: Demonstration using HPLC and radioligand binding. Life Sci. 1995;57:609\u2013615. doi: 10.1016/0024-3205(95)00311-S.", "ArticleIdList": ["10.1016/0024-3205(95)00311-S", "7623628"]}, {"Citation": "Brown G.P., Yang K., Ouerfelli O., Standifer K.M., Byrd D., Pasternak G.W. 3H-morphine-6\u03b2-glucuronide binding in brain membranes and an MOR-1- transfected cell line. J. Pharmacol. Exp. Ther. 1997;282:1291\u20131297.", "ArticleIdList": ["9316837"]}, {"Citation": "Peat S.J., Hanna M.H., Woodham M., Knibb A.A., Ponte J. Morphine-6-glucuronide: Effects on ventilation in normal volunteers. Pain. 1991;45:101\u2013104. doi: 10.1016/0304-3959(91)90170-3.", "ArticleIdList": ["10.1016/0304-3959(91)90170-3", "1907362"]}, {"Citation": "Thompson P.I., Joel S.P., John L., Wedzicha J.A., Maclean M., Slevin M.L. Respiratory depression following morphine and morphine-6-glucuronide in normal subjects. Br. J. Clin. Pharmacol. 1995;40:145\u2013152.", "ArticleIdList": ["PMC1365174", "8562297"]}, {"Citation": "Noszal B., Hosztafi S. Physicochemical and Pharmacological Characterization of Permanently Charged Opioids. Curr. Med. Chem. 2017;24:3633\u20133648. doi: 10.2174/0929867324666170705112239.", "ArticleIdList": ["10.2174/0929867324666170705112239", "28685673"]}, {"Citation": "Pavan B., Dalpiaz A., Ciliberti N., Biondi C., Manfredini S., Vertuani S. Progress in Drug Delivery to the Central Nervous System by the Prodrug Approach. Molecules. 2008;13:1035\u20131065. doi: 10.3390/molecules13051035.", "ArticleIdList": ["10.3390/molecules13051035", "PMC6245073", "18560328"]}, {"Citation": "Varghese V., Hudlicky T. A Short History of the Discovery and Development of Naltrexone and Other Morphine Derivatives. Nat. Prod. Med. Chem. 2014;60:225\u2013250. doi: 10.1002/9783527676545.ch06.", "ArticleIdList": ["10.1002/9783527676545.ch06"]}, {"Citation": "Ortiz de Montellano P.R. Cytochrome P450-activated prodrug. Future Med. Chem. 2013;2:213\u2013228. doi: 10.4155/fmc.12.197.", "ArticleIdList": ["10.4155/fmc.12.197", "PMC3697796", "23360144"]}, {"Citation": "L\u00f6tsch J. Opioid Metabolites. J. Pain Symptom Manag. 2005;29:10\u201324. doi: 10.1016/j.jpainsymman.2005.01.004.", "ArticleIdList": ["10.1016/j.jpainsymman.2005.01.004", "15907643"]}, {"Citation": "Filer C.N. Morphinan alkaloids labeled with tritium: Synthesis and applications. J. Label. Compd. Radiopharm. 2013;56:639\u2013648. doi: 10.1002/jlcr.3094.", "ArticleIdList": ["10.1002/jlcr.3094", "25196025"]}, {"Citation": "Toth G. Tritiated Opioid Receptor Ligands as Radiotracers. Curr. Pharm. Des. 2014;19:7461\u20137472. doi: 10.2174/138161281942140105170259.", "ArticleIdList": ["10.2174/138161281942140105170259", "23448471"]}, {"Citation": "Speyer E., Rosenfeld H. Darstellung von Monobrom- und Monochlor-kodein und ihr Verhalten bei der katalytischen Reduktion. Ber. Dtsch. Chem. Ges. 1925;58:1110\u20131113. doi: 10.1002/cber.19250580622.", "ArticleIdList": ["10.1002/cber.19250580622"]}, {"Citation": "Weiss U., Singh B.B., Chauhan R.S., Madyastha K.M., Bhatnagar S.P., Kirk K.L. 1- and 2-Chloromorphine. Halogenation of Morphine meta to the Free Phenolic Hydroxyl Group. Heterocycles. 1982;19:837. doi: 10.3987/R-1982-05-0837.", "ArticleIdList": ["10.3987/R-1982-05-0837"]}, {"Citation": "Anderson T. Ueber die Constitution des Code\u00efns und seine Zersetzungsproducte. Eur. J. Org. Chem. 1851;77:341\u2013382. doi: 10.1002/jlac.18510770309.", "ArticleIdList": ["10.1002/jlac.18510770309"]}, {"Citation": "Barmaki S., Ali A., Desaulniers J.-P., Bolshan Y. Bromination of codeine and its derivatives: Revisiting a 95 year old process. Tetrahedron Lett. 2020;61:152234. doi: 10.1016/j.tetlet.2020.152234.", "ArticleIdList": ["10.1016/j.tetlet.2020.152234"]}, {"Citation": "Braenden O.J., Eddy N.B., Halbach H. Synthetic substances with morphine-like effect; relationship between chemical structure and analgesic action. Bull. World Health Organ. 1955;13:937\u2013998.", "ArticleIdList": ["PMC2538094", "13284565"]}, {"Citation": "Simon C., Hosztafi S., Makleit S. Application of the Mitsunobu reaction in the morphine series.: The reaction of 14\u03b2-chloro and 14\u03b2-bromocodeine with phthalimide and diphenylphosphoryl azide. Tetrahedron Lett. 1993;34:6475\u20136478. doi: 10.1016/0040-4039(93)85074-7.", "ArticleIdList": ["10.1016/0040-4039(93)85074-7"]}, {"Citation": "Lousberg R.J.J.C., Weiss U. The analgesic action of 1-fluorocodeine. Cell. Mol. Life Sci. 1974;30:1440\u20131441. doi: 10.1007/BF01919684.", "ArticleIdList": ["10.1007/BF01919684", "4442543"]}, {"Citation": "Ojima I. Fluorine in Medicinal Chemistry and Chemical Biology. John Wiley & Sons; Hoboken, NJ, USA: 2009.", "ArticleIdList": ["10.1002/9781444312096"]}, {"Citation": "Hagmann W.K. The Many Roles for Fluorine in Medicinal Chemistry. J. Med. Chem. 2008;51:4359\u20134369. doi: 10.1021/jm800219f.", "ArticleIdList": ["10.1021/jm800219f", "18570365"]}, {"Citation": "Purser S., Moore P.R., Swallow S., Gouverneur V. Fluorine in medicinal chemistry. Chem. Soc. Rev. 2007;37:320\u2013330. doi: 10.1039/B610213C.", "ArticleIdList": ["10.1039/B610213C", "18197348"]}, {"Citation": "Gillis E.P., Eastman K.J., Hill M.D., Donnelly D.J., Meanwell N.A. Applications of Fluorine in Medicinal Chemistry. J. Med. Chem. 2015;58:8315\u20138359. doi: 10.1021/acs.jmedchem.5b00258.", "ArticleIdList": ["10.1021/acs.jmedchem.5b00258", "26200936"]}, {"Citation": "Hosztafi S., Marton J. Synthesis of 1-fluoro-substituted codeine derivatives. Chem. Pap. 2016;70:973\u2013982. doi: 10.1515/chempap-2016-0033.", "ArticleIdList": ["10.1515/chempap-2016-0033"]}, {"Citation": "Makleit S., Dubina V. A gram scale preparation of 1-fluorocodeine and 1-fluorodihydrocodeine. ACH-Model. Chem. 2000;137:447\u2013449."}, {"Citation": "Enginar H., Unak P., Lambrecht F.Y., M\u00fcft\u00fcler F.Z.B., Medine E.I., Yolcular S., Yurt A., Seyitoglu B., Bulduk I. Radiolabeling of codeine with 131I and its biodistribution in rats. J. Radioanal. Nucl. Chem. 2009;280:363\u2013370. doi: 10.1007/s10967-009-0528-2.", "ArticleIdList": ["10.1007/s10967-009-0528-2"]}, {"Citation": "Tafani J., Lazorthes Y., Danet B., Verdie J., Esquerre J., Simon J., Guiraud R. Human brain and spinal cord scan after intracerebroventricular administration of iodine-123 morphine. Int. J. Radiat. Appl. Instrum. Part B Nucl. Med. Biol. 1989;16:505\u2013509. doi: 10.1016/0883-2897(89)90064-0.", "ArticleIdList": ["10.1016/0883-2897(89)90064-0", "2807956"]}, {"Citation": "Kumada N., Kinomura N. Preparation and Crystal Structure of K2YNb5O15\u2212\u03b4. J. Solid State Chem. 1996;123:285\u2013290. doi: 10.1006/jssc.1996.0180.", "ArticleIdList": ["10.1006/jssc.1996.0180"]}, {"Citation": "Davies S.G., Goodwin C.J., Pyatt D., Smith A.D. Palladium catalysed elaboration of codeine and morphine. J. Chem. Soc. Perkin Trans. 1. 2001;2:1413\u20131420. doi: 10.1039/b102581n.", "ArticleIdList": ["10.1039/b102581n"]}, {"Citation": "Milstein D., Stille J.K. Palladium-catalyzed coupling of tetraorganotin compounds with aryl and benzyl halides. Synthetic utility and mechanism. J. Am. Chem. Soc. 1979;101:4992\u20134998. doi: 10.1021/ja00511a032.", "ArticleIdList": ["10.1021/ja00511a032"]}, {"Citation": "Davies S.G., Pyatt D. Synthesis of 1-Substituted Derivatives of Codeine from 1-Bromocodeine via Palladium Catalysed Coupling Reactions. Heterocycles. 1989;28:163. doi: 10.3987/COM-88-S71.", "ArticleIdList": ["10.3987/COM-88-S71"]}, {"Citation": "Gir\u00e1n L., Ber\u00e9nyi S., Sipos A. Formation of novel thiazolomorphinans and thiazoloaporphines. Tetrahedron. 2008;64:10388\u201310394. doi: 10.1016/j.tet.2008.08.069.", "ArticleIdList": ["10.1016/j.tet.2008.08.069"]}, {"Citation": "Chatterjie N., Minar A., Clarke D.D. Synthesis of 2-Aminomorphine and 2-Aminocodeine. Reduction of Aromatic Nitro Groups with Formamidinesulfinic Acid. Synth. Commun. 1979;9:647\u2013657. doi: 10.1080/00397917908066712.", "ArticleIdList": ["10.1080/00397917908066712"]}, {"Citation": "Kaufmann H.P., Oehring W., Clauberg A. Wissenschaftlicher Teil.: Die Bildung von Thiazol-Derivaten bei der Rhodanierung von Aminen. Arch. Pharm. 1928;266:197\u2013218. doi: 10.1002/ardp.192800069.", "ArticleIdList": ["10.1002/ardp.192800069"]}, {"Citation": "Canka\u0159 P., Popa I., Tr\u00e1vn\u00ed\u010dek Z., St\u00fdskala J., Hradil P., Slouka J. Synthesis of 1-Aminocodeine as a Synthon for Other Codeine Derivatives. Eur. J. Org. Chem. 2013;2013:6062\u20136068. doi: 10.1002/ejoc.201300701.", "ArticleIdList": ["10.1002/ejoc.201300701"]}, {"Citation": "Hedberg M.H., Johansson A.M., Fowler C.J., Terenius L., Hacksell U. Palladium-catalyzed synthesis of C3-substituted 3-deoxymorphines. Bioorganic Med. Chem. Lett. 1994;4:2527\u20132532. doi: 10.1016/S0960-894X(01)80277-8.", "ArticleIdList": ["10.1016/S0960-894X(01)80277-8"]}, {"Citation": "Wentland M.P., Xu G., Cioffi C.L., Ye Y., Duan W., Cohen D.J., Colasurdo A.M., Bidlack J.M. 8-Aminocyclazocine analogues: Synthesis and structure\u2013activity relationships. Bioorganic Med. Chem. Lett. 2000;10:183\u2013187. doi: 10.1016/S0960-894X(99)00670-8.", "ArticleIdList": ["10.1016/S0960-894X(99)00670-8", "10673107"]}, {"Citation": "Louie J., Driver M.S., Hamann B.C., Hartwig J.F. Palladium-Catalyzed Amination of Aryl Triflates and Importance of Triflate Addition Rate. J. Org. Chem. 1997;62:1268\u20131273. doi: 10.1021/jo961930x.", "ArticleIdList": ["10.1021/jo961930x"]}, {"Citation": "Wentland M.P., Duan W., Cohen D.J., Bidlack J.M. Selective Protection and Functionalization of Morphine: Synthesis and Opioid Receptor Binding Properties of 3-Amino-3-desoxymorphine Derivatives,1. J. Med. Chem. 2000;43:3558\u20133565. doi: 10.1021/jm000119i.", "ArticleIdList": ["10.1021/jm000119i", "11000010"]}, {"Citation": "Zhang A., Xiong W., Hilbert J.E., DeVita E.K., Bidlack J.M., Neumeyer J.L. 2-Aminothiazole-Derived Opioids. Bioisosteric Replacement of Phenols. J. Med. Chem. 2004;47:1886\u20131888. doi: 10.1021/jm049978n.", "ArticleIdList": ["10.1021/jm049978n", "15055988"]}, {"Citation": "And\u00e9n N.-E., Nilsson H., Ros E., Thornstr\u00f6m U. Effects of B-HT 920 and B-HT 933 on Dopamine and Noradrenaline Autoreceptors in the Rat Brain. Acta Pharmacol. Toxicol. 1983;52:51\u201356. doi: 10.1111/j.1600-0773.1983.tb01075.x.", "ArticleIdList": ["10.1111/j.1600-0773.1983.tb01075.x", "6301216"]}, {"Citation": "Jaen J.C., Wise L.D., Caprathe B.W., Tecle H.B.S., Humblet C.C., Heffner T.G., Meltzer L.T., Pugsley T.A. 4-(1,2,5,6-Tetrahydro-1-alkyl-3-pyridinyl)-2-thiazolamines: A novel class of compounds with central dopamine agonist proper-ties. J. Med. Chem. 1990;33:311\u2013317. doi: 10.1021/jm00163a051.", "ArticleIdList": ["10.1021/jm00163a051", "1967314"]}, {"Citation": "Salvatella M., Arsequell G., Valencia G., Rodr\u00edguez R.E. A highly toxic morphine-3-glucuronide derivative. Bioorganic Med. Chem. Lett. 2004;14:905\u2013908. doi: 10.1016/j.bmcl.2003.12.016.", "ArticleIdList": ["10.1016/j.bmcl.2003.12.016", "15012991"]}, {"Citation": "Jash S.K., Gorai D. Sugar Derivatives of Morphine: A New Window for the Development of Potent Anesthetic Drugs. Nat. Prod. Bioprospecting. 2015;5:111\u2013127. doi: 10.1007/s13659-015-0060-8.", "ArticleIdList": ["10.1007/s13659-015-0060-8", "PMC4488153", "25997823"]}, {"Citation": "Stork G., Clarke F.H. The SN2\u2019 Reaction. III. Structure and SN2\u2032 Reactions of the Halocodides. J. Am. Chem. Soc. 1956;78:4619\u20134624. doi: 10.1021/ja01599a026.", "ArticleIdList": ["10.1021/ja01599a026"]}, {"Citation": "Yeh H.J., Wilson R.S., Klee W.A., Jacobson A.E. \u03b1- and \u03b2-halomorphides: Stereochemistry, analgesic potency, toxicity, and interaction with narcotic receptors in vitro. J. Pharm. Sci. 1976;65:902\u2013904. doi: 10.1002/jps.2600650624.", "ArticleIdList": ["10.1002/jps.2600650624", "932978"]}, {"Citation": "Simon C., Hosztafi S., Makleit S. The First Preparation of 6\u03b2-Bromo Codeine and Morphine Derivatives. Kinetic vs. Thermodynamic Control. J. Chem. Res. 1997:437. doi: 10.1039/a704502f.", "ArticleIdList": ["10.1039/a704502f"]}, {"Citation": "Fujii I., Togame H., Yamamoto M., Kanematsu K., Takayanagi I., Konno F. Design and synthesis of sulfur-containing morphine and an opioid receptor probe. Chem. Pharm. Bull. 1988;36:2282\u20132285. doi: 10.1248/cpb.36.2282.", "ArticleIdList": ["10.1248/cpb.36.2282", "2853649"]}, {"Citation": "Kanematsu K., Naito R., Shimohigashi Y., Ohno M., Ogasawara T., Kurono M., Yagi K. Design and synthesis of an opioid receptor probe: Mode of binding of S-activated (-)-6.BETA.-sulfhydryldihydromorphine with the SH group in the .MU.-opioid receptor. Chem. Pharm. Bull. 1990;38:1438\u20131440. doi: 10.1248/cpb.38.1438.", "ArticleIdList": ["10.1248/cpb.38.1438", "1975519"]}, {"Citation": "Kumagai H., Ebata T., Takamori K., Muramatsu T., Nakamoto H., Suzuki H. Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337 haemodialysis patients: A Phase III, randomized, double-blind, placebo-controlled study. Nephrol. Dial. Transplant. 2009;25:1251\u20131257. doi: 10.1093/ndt/gfp588.", "ArticleIdList": ["10.1093/ndt/gfp588", "19926718"]}, {"Citation": "Sayre L.M., Larson D.L., Takemori A.E., Portoghese P.S. Design and synthesis of naltrexone-derived affinity labels with nonequilibrium opioid agonist and antagonist activities. Evidence for the existence of different .mu. receptor subtypes in different tissues. J. Med. Chem. 1984;27:1325\u20131335. doi: 10.1021/jm00376a018.", "ArticleIdList": ["10.1021/jm00376a018", "6090663"]}, {"Citation": "Majumdar S., Burgman M., Haselton N., Grinnell S., Ocampo J., Pasternak A.R., Pasternak G.W. Generation of novel radiolabeled opiates through site-selective iodination. Bioorganic Med. Chem. Lett. 2011;21:4001\u20134004. doi: 10.1016/j.bmcl.2011.05.008.", "ArticleIdList": ["10.1016/j.bmcl.2011.05.008", "PMC3115495", "21621410"]}, {"Citation": "Mitsunobu O. The Use of Diethyl Azodicarboxylate and Triphenylphosphine in Synthesis and Transformation of Natural Products. Synthesis. 1981;1981:1\u201328. doi: 10.1055/s-1981-29317.", "ArticleIdList": ["10.1055/s-1981-29317"]}, {"Citation": "Simon C., Hosztafi S., Makleit S. Application of the mitsunobu reaction in the field of alkaloids. J. Heterocycl. Chem. 1997;34:349\u2013365. doi: 10.1002/jhet.5570340201.", "ArticleIdList": ["10.1002/jhet.5570340201"]}, {"Citation": "Munawar S., Zahoor A.F., Ali S., Javed S., Irfan M., Irfan A., Kotwica-Mojzych K., Mojzych M. Mitsunobu Reaction: A Powerful Tool for the Synthesis of Natural Products: A Review. Molecules. 2022;27:6953. doi: 10.3390/molecules27206953.", "ArticleIdList": ["10.3390/molecules27206953", "PMC9609662", "36296545"]}, {"Citation": "Bogn\u00e1r R., Makleit S. Conversions of tosyl and mesyl derivatives of morphine group. 2. aminomorphides and aminocodides preliminary communication. Acta Chim. Acad. Sci. Hung. 1968;58:203\u2013205."}, {"Citation": "Elliott H., Meredith P., Vincent J., Reid J. Clinical pharmacological studies with doxazosin. Br. J. Clin. Pharmacol. 1986;21:27S\u201331S. doi: 10.1111/j.1365-2125.1986.tb02850.x.", "ArticleIdList": ["10.1111/j.1365-2125.1986.tb02850.x", "PMC1400752", "2871854"]}, {"Citation": "Knoll J., Furst S., Kelemen K. The pharmacology of azidomorphine and azidocodeine. J. Pharm. Pharmacol. 1973;25:929\u2013939. doi: 10.1111/j.2042-7158.1973.tb09982.x.", "ArticleIdList": ["10.1111/j.2042-7158.1973.tb09982.x", "4150295"]}, {"Citation": "Knoll J. Azidomorphine and rymazolium an approach to the ideal analgesic. Pharmacol. Res. Commun. 1973;5:175\u2013191. doi: 10.1016/S0031-6989(73)80035-9.", "ArticleIdList": ["10.1016/S0031-6989(73)80035-9"]}, {"Citation": "Urai \u00c1., V\u00e1radi A., Sz\u0151cs L., Komj\u00e1ti B., Le Rouzic V., Hunkele A., Pasternak G.W., Majumdar S., Hosztafi S. Synthesis and pharmacological evaluation of novel selective MOR agonist 6\u03b2-pyridinyl amidomorphines exhibiting long-lasting antinociception. MedChemComm. 2016;8:152\u2013157. doi: 10.1039/C6MD00450D.", "ArticleIdList": ["10.1039/C6MD00450D", "PMC5464418", "28603600"]}, {"Citation": "Knoll J. Azidomorphines: A new family of potent analgesics with low dependence capacity. Prog. Neuro-Psychopharmacol. 1979;3:95\u2013108. doi: 10.1016/0364-7722(79)90074-2.", "ArticleIdList": ["10.1016/0364-7722(79)90074-2", "45567"]}, {"Citation": "MacDougall J.M., Zhang X.-D., Polgar W.E., Khroyan T.V., Toll L., Cashman J.R. Synthesis and biological evaluation of some 6-arylamidomorphines as analogues of morphine-6-glucuronide. Bioorganic Med. Chem. 2004;12:5983\u20135990. doi: 10.1016/j.bmc.2004.08.019.", "ArticleIdList": ["10.1016/j.bmc.2004.08.019", "15498674"]}, {"Citation": "V\u00e1radi A., Hosztafi S., Le Rouzic V., T\u00f3th G., Urai \u00c1., Nosz\u00e1l B., Pasternak G.W., Grinnell S.G. Novel 6\u03b2-acylaminomorphinans with analgesic activity. Eur. J. Med. Chem. 2013;69:786\u2013789. doi: 10.1016/j.ejmech.2013.09.031.", "ArticleIdList": ["10.1016/j.ejmech.2013.09.031", "PMC3839676", "24103580"]}, {"Citation": "V\u00e1radi A., Marrone G.F., Eans S.O., Ganno M.L., Subrath J.J., Le Rouzic V., Hunkele A., Pasternak G.W., McLaughlin J.P., Majumdar S. Synthesis and Characterization of a Dual Kappa-Delta Opioid Receptor Agonist Analgesic Blocking Cocaine Reward Behavior. ACS Chem. Neurosci. 2015;6:1813\u20131824. doi: 10.1021/acschemneuro.5b00153.", "ArticleIdList": ["10.1021/acschemneuro.5b00153", "PMC4651729", "26325040"]}, {"Citation": "Li G., Aschenbach L.C., Chen J., Cassidy M.P., Stevens D.L., Gabra B.H., Selley D.E., Dewey W.L., Westkaemper R.B., Zhang Y. Corrections to Design, Synthesis, and Biological Evaluation of 6\u03b1- and 6\u03b2-N-Heterocyclic Substituted Naltrexamine Derivatives as \u03bc Opioid Receptor Selective Antagonists. J. Med. Chem. 2009;52:8057. doi: 10.1021/jm9016224.", "ArticleIdList": ["10.1021/jm9016224", "PMC2880636", "19199782"]}, {"Citation": "Arsequell G., Salvatella M., Valencia G., Fern\u00e1ndez-Mayoralas A., Fontanella M., Venturi C., Jim\u00e9nez-Barbero J., Marr\u00f3n E., Rodr\u00edguez R.E. Synthesis, Conformation, and Biological Characterization of a Sugar Derivative of Morphine that is a Potent, Long-Lasting, and Nontolerant Antinociceptive. J. Med. Chem. 2009;52:2656\u20132666. doi: 10.1021/jm8011245.", "ArticleIdList": ["10.1021/jm8011245", "19351163"]}, {"Citation": "MacDougall J.M., Zhang X.-D., Polgar W.E., Khroyan T.V., Toll L., Cashman J.R. Design, Chemical Synthesis, and Biological Evaluation of Thiosaccharide Analogues of Morphine- and Codeine-6-Glucuronide. J. Med. Chem. 2004;47:5809\u20135815. doi: 10.1021/jm049554t.", "ArticleIdList": ["10.1021/jm049554t", "15509180"]}, {"Citation": "MacDougall J.M., Zhang X.-D., Polgar W.E., Khroyan T.V., Toll L., Cashman J.R. Synthesis and in vitro biological evaluation of a carbon glycoside analogue of morphine-6-glucuronide. Bioorganic Med. Chem. Lett. 2005;15:1583\u20131586. doi: 10.1016/j.bmcl.2005.01.072.", "ArticleIdList": ["10.1016/j.bmcl.2005.01.072", "15745801"]}, {"Citation": "Yang J., Lu G., Zhang G., Wang X., Wen H., Huang C., Yin J., Li J. Morphine-6-Glucuronide Isomers-Synthesis and Biological Evaluation. Bull. Korean Chem. Soc. 2020;41:1073\u20131079. doi: 10.1002/bkcs.12112.", "ArticleIdList": ["10.1002/bkcs.12112"]}, {"Citation": "Thavaneswaran S., Mccamley K., Scammells P.J. N-Demethylation of Alkaloids. Nat. Prod. Commun. 2006;1:2006. doi: 10.1177/1934578X0600101008.", "ArticleIdList": ["10.1177/1934578X0600101008"]}, {"Citation": "Machara A., Hudlick\u00fd T. Advances in N- and O-demethylation of opiates. Targets Heterocycl. Syst. 2016;20:113\u2013138. doi: 10.17374/TARGETS.2017.20.113.", "ArticleIdList": ["10.17374/TARGETS.2017.20.113"]}, {"Citation": "McCamley K., Ripper J.A., Singer R.D., Scammells P.J. Efficient N-Demethylation of Opiate Alkaloids Using a Modified Nonclassical Polonovski Reaction. J. Org. Chem. 2003;68:9847\u20139850. doi: 10.1021/jo035243z.", "ArticleIdList": ["10.1021/jo035243z", "14656122"]}, {"Citation": "Ripper J.A., Tiekink R.T., Scammells P.J. Photochemical N -Demethylation of Alkaloids. Bioorg. Med. Chem. Lett. 2001;11:443\u2013445. doi: 10.1016/S0960-894X(00)00690-9.", "ArticleIdList": ["10.1016/S0960-894X(00)00690-9", "11229743"]}, {"Citation": "Chaudhary V., Leisch H., Moudra A., Allen B., De Luca V., Cox D.P., Hudlick\u00fd T. Biotransformations of morphine alkaloids by fungi: N-demethylations, oxidations, and reductions. Collect. Czechoslov. Chem. Commun. 2009;74:1179\u20131193. doi: 10.1135/cccc2009025.", "ArticleIdList": ["10.1135/cccc2009025"]}, {"Citation": "Morton A.A., Olson A.R., Blattenberger J.W. Thioanilides of Malonic Acids. J. Am. Chem. Soc. 1941;63:314\u2013315. doi: 10.1021/ja01846a505.", "ArticleIdList": ["10.1021/ja01846a505"]}, {"Citation": "Unna K. Antagonistic effect of N-allyl-normorphine upon morphine. J. Pharmacol. Exp. Ther. 1943;79:28\u201331. doi: 10.1016/0014-2999(84)90254-1.", "ArticleIdList": ["10.1016/0014-2999(84)90254-1"]}, {"Citation": "Clark R.L., Pessolano A.A., Weijlard J., Pfister K., 3rd N-Substituted Epoxymorphinan. J. Am. Chem. Soc. 1953;75:4963\u20134967. doi: 10.1021/ja01116a024.", "ArticleIdList": ["10.1021/ja01116a024"]}, {"Citation": "Small L., Eddy N., Ager J., May E. Notes: An Improved Synthesis of N-Phenethylnormorphine and Analogs. J. Org. Chem. 1958;23:1387\u20131388. doi: 10.1021/jo01103a615.", "ArticleIdList": ["10.1021/jo01103a615"]}, {"Citation": "Ben Haddou T., B\u00e9ni S., Hosztafi S., Malfacini D., Calo G., Schmidhammer H., Spetea M. Pharmacological Investigations of N-Substituent Variation in Morphine and Oxymorphone: Opioid Receptor Binding, Signaling and Antinociceptive Activity. PLoS ONE. 2014;9:e99231. doi: 10.1371/journal.pone.0099231.", "ArticleIdList": ["10.1371/journal.pone.0099231", "PMC4053365", "24919067"]}, {"Citation": "Gharehnaghadeh S., Salehi P., Bararjanian M., Pecio \u0141., Babanezhad-Harikandei K., Khoramjouy M., Shahhosseini S., Faizi M. Novel Triazole-Tethered Derivatives of Nor-codeine: Synthesis, Radioligand Binding Assay, Docking Study and Evaluation of Their Analgesic Properties. Chemistryselect. 2020;5:14753\u201314758. doi: 10.1002/slct.202003684.", "ArticleIdList": ["10.1002/slct.202003684"]}, {"Citation": "Brown C.E., Roerig S.C., Burger V.T., Cody R.B., Fujimoto J.M. Analgesic Potencies of Morphine 3- and 6-Sulfates After Intracerebroventricular Administration in Mice: Relationship to Structural Characteristics Defined by Mass Spectrometry and Nuclear Magnetic Resonance. J. Pharm. Sci. 1985;74:821\u2013824. doi: 10.1002/jps.2600740804.", "ArticleIdList": ["10.1002/jps.2600740804", "4032263"]}, {"Citation": "Houdi A.A., Kottayil S., Crooks P.A., Butterfield D. 3-O-Acetylmorphine-6-O-sulfate: A potent, centrally acting morphine derivative. Pharmacol. Biochem. Behav. 1996;53:665\u2013671. doi: 10.1016/0091-3057(95)02067-5.", "ArticleIdList": ["10.1016/0091-3057(95)02067-5", "8866970"]}, {"Citation": "Zuckerman A., Bolan E., de Paulis T., Schmidt D., Spector S., Pasternak G.W. Pharmacological characterization of morphine-6-sulfate and codeine-6-sulfate. Brain Res. 1999;842:1\u20135. doi: 10.1016/S0006-8993(99)01766-7.", "ArticleIdList": ["10.1016/S0006-8993(99)01766-7", "10526089"]}, {"Citation": "Crooks P.A., Kottayil S.G., Al-Ghananeem A.M., Byrn S.R., Butterfield D.A. Opiate receptor binding properties of morphine-, dihydromorphine-, and codeine 6-O-sulfate ester congeners. Bioorganic Med. Chem. Lett. 2006;16:4291\u20134295. doi: 10.1016/j.bmcl.2006.05.060.", "ArticleIdList": ["10.1016/j.bmcl.2006.05.060", "16777416"]}, {"Citation": "Dietis N., Rowbotham D., Lambert D. Opioid receptor subtypes: Fact or artifact? Br. J. Anaesth. 2011;107:8\u201318. doi: 10.1093/bja/aer115.", "ArticleIdList": ["10.1093/bja/aer115", "21613279"]}, {"Citation": "V\u00e1radi A., Gergely A., B\u00e9ni S., Jankovics P., Nosz\u00e1l B., Hosztafi S. Sulfate esters of morphine derivatives: Synthesis and characterization. Eur. J. Pharm. Sci. 2011;42:65\u201372. doi: 10.1016/j.ejps.2010.10.007.", "ArticleIdList": ["10.1016/j.ejps.2010.10.007", "21034820"]}, {"Citation": "Hosztafi S., Kraszni M., T\u00f3th G., Marton J. Synthesis of 1-Iodo-substituted Codeine Derivatives. Lett. Org. Chem. 2018;15:1012\u20131020. doi: 10.2174/1570178615666171222163442.", "ArticleIdList": ["10.2174/1570178615666171222163442"]}, {"Citation": "Shel\u2019Metsi D., Slavik L., Kashkete Z., Lilek L.-M., Matsko I. Synthesis of new morphine derivatives. Pharm. Chem. J. 1968;2:302\u2013306. doi: 10.1007/BF00759723.", "ArticleIdList": ["10.1007/BF00759723"]}, {"Citation": "Simon C., Hosztafi S., Makleit S. Application of the Mitsunobu Reaction for Morphine Compounds. Preparation of 6\u03b2-Aminomorphine and Codeine Derivatives. Synth. Commun. 1992;22:913\u2013921. doi: 10.1080/00397919208020855.", "ArticleIdList": ["10.1080/00397919208020855"]}, {"Citation": "Simon C., Hosztafi S., Makleit S. Application of the Mitsunobu Reaction for the Preparation of Isomorphine and Isocodeine Derivatives. Synth. Commun. 1991;21:407\u2013412. doi: 10.1080/00397919108016763.", "ArticleIdList": ["10.1080/00397919108016763"]}, {"Citation": "Hirano T., Oguri K., Yoshimura H. Synthesis and Pharmacological Activity of Sulfate Conjugates at 6-Position of N-Substituted Normorphine Derivatives. Chem. Pharm. Bull. 1991;39:2000\u20132004. doi: 10.1248/cpb.39.2000.", "ArticleIdList": ["10.1248/cpb.39.2000", "1797421"]}, {"Citation": "Olofson R.A., Martz J.T., Senet J.P., Piteau M., Malfroot T. A new reagent for the selective, high-yield N-dealkylation of tertiary amines: Improved syntheses of naltrexone and nalbuphine. J. Org. Chem. 1984;49:2081\u20132082. doi: 10.1021/jo00185a072.", "ArticleIdList": ["10.1021/jo00185a072"]}], "ReferenceList": []}], "History": [{"Year": "2023", "Month": "4", "Day": "30"}, {"Year": "2023", "Month": "6", "Day": "14"}, {"Year": "2023", "Month": "6", "Day": "15"}, {"Year": "2023", "Month": "6", "Day": "28", "Hour": "6", "Minute": "43"}, {"Year": "2023", "Month": "6", "Day": "28", "Hour": "6", "Minute": "42"}, {"Year": "2023", "Month": "6", "Day": "28", "Hour": "1", "Minute": "37"}, {"Year": "2023", "Month": "6", "Day": "20"}], "PublicationStatus": "epublish", "ArticleIdList": ["37376226", "PMC10304093", "10.3390/pharmaceutics15061779", "pharmaceutics15061779"]}}], "PubmedBookArticle": []}